Acquisition of specific human respiratory tract binding by 2.3.4.4b H5N1 hemagglutinins requires multiple mutations.

María Ríos Carrasco1 Mafalda F Guerreiro Cabana1 Eszter Kovács1 Zoé Ducarne1 Cindy G J Cleypool2 Geert-Jan Boons1,3 Robert P de Vries1
Affiliations 3 institutions
  1. Department of Chemical Biology & Drug Discovery, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands.
  2. Division of Surgical Specialties, Department of Anatomy, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
  3. Complex Carbohydrate Research Center, University of Georgia, Athens, Georgia, USA.

Abstract

It has been suggested that the hemagglutinin of the human-infecting cattle-derived 2.3.4.4b virus A/Texas/34 H5N1 (H5TX) requires only one mutation, namely Q226L, to switch from binding avian-type to human-type receptor preference. In this study, we examined the binding of H5TX Q226L, along with other key mutations, to sections of human trachea. We conclude that, while H5TX Q226L can bind human-type receptors, more than a single mutation is required for this protein to bind to human respiratory tract tissue. We also report changes in receptor-binding specificity of another 2.3.4.4b HA mutant, H5FR Q226L (from A/duck/France/161108/16 H5N8), associated with the presence of a multibasic cleavage site. This study offers insight into the determinants of evolution toward human-type receptor binding in currently circulating H5Nx viruses. It also emphasizes the importance of testing individual strains using additional methods, including tissue-based approaches, alongside synthetic glycans.IMPORTANCECurrently, H5N1 influenza A viruses are responsible for numerous zoonotic spillover events, from infecting birds to other mammals, including dairy cattle. Although no human-to-human transmission has been observed, several people have been infected. This host range expansion is typically linked to changes in one of the viral surface proteins, hemagglutinin, which can switch its preference from avian-type to human-type receptors. To better understand the potential of the currently circulating H5N1 virus to transmit among humans, we evaluated the effects of the Q226L mutation, in combination with other amino acid substitutions, on binding to the human trachea. We also studied the effect of the multibasic cleavage site, a specific motif present in highly pathogenic influenza strains, on receptor-binding properties. These findings provide insight into the role of receptor binding in influenza infections.

Supporting text Virus Host Location
2.3.4.4b H5N1 2 hemagglutinin 31 influenza 61 N-glycan 1 receptor binding 30 sialic acid 12

Evidence records

4 total
Experimental Infection
2 records · 1 evidence types
Evidence type
2 records
OVE11975
Key finding

H5TX Q226L binds human-type receptors but requires additional mutations to bind human tracheal tissue in tissue-based assays.

Virus
Host
Experimental system Experimental system Context pending
Location
Not specified
Supporting text

In this study, we examined the binding of H5TX Q226L, along with other key mutations, to sections of human trachea. We conclude that, while H5TX Q226L can bind human-type receptors, more than a single mutation is required for this protein to bind to human respiratory tract tissue.

Method
tissue-based binding assay
Sample type
sections of human trachea
Experimental system
tissue-based receptor/tissue binding assay using human tracheal sections
OVE11976
Key finding

The H5FR Q226L hemagglutinin from A/duck/France/161108/16 H5N8 shows altered receptor-binding specificity associated with the presence of a multibasic cleavage site.

Virus
Host
Location
Not specified
Supporting text

We also report changes in receptor-binding specificity of another 2.3.4.4b HA mutant, H5FR Q226L (from A/duck/France/161108/16 H5N8), associated with the presence of a multibasic cleavage site.

Method
receptor-binding assay
Experimental system
receptor-binding specificity assay
Functional Mechanism
2 records · 1 evidence types
Evidence type
2 records
OVE11973
Key finding

The H5TX Q226L hemagglutinin binds human-type receptors but alone is insufficient for binding to human respiratory tract tissue.

Virus
Host
Experimental system Experimental system
Location
Not specified
Supporting text

We conclude that, while H5TX Q226L can bind human-type receptors, more than a single mutation is required for this protein to bind to human respiratory tract tissue.

Method
glycan-binding assay | human tracheal tissue binding assay
Receptors
human-type receptors
OVE11974
Key finding

The H5FR Q226L (H5N8) hemagglutinin shows altered receptor-binding specificity associated with the presence of a multibasic cleavage site.

Virus
Host
Not specified
Location
Not specified
Supporting text

We also report changes in receptor-binding specificity of another 2.3.4.4b HA mutant, H5FR Q226L (from A/duck/France/161108/16 H5N8), associated with the presence of a multibasic cleavage site.

Method
receptor-binding assay
Receptors
receptor-binding specificity
Host factors
multibasic cleavage site